Article in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Samuel Sarmiento DoncelIntegral Solutions SD SAS, Integral Solutions Research, Bogota 110121, Colombia.
Ronald Guillermo PeláezLife Sciences and Health Research Group, Graduates School, CES University, Medellin 050021, Colombia.ORCID 0000-0002-2815-9844
Pablo LapunzinaInstituto de Genética Médica y Molecular (INGEMM), IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.ORCID 0000-0002-6324-4825
Fernando F Corrales-MedinaDivision of Pediatric Hematology-Oncology, Department of Pediatrics, University of Miami-Miller School of Medicine, Miami, FL 33136, USA.ORCID 0000-0001-6185-4809
Santiago BonanadHospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.ORCID 0000-0002-8390-8211
Javier Mauricio CortesIntegral Solutions SD SAS, Integral Solutions Research, Bogota 110121, Colombia.
Mario CazallaInstituto de Genética Médica y Molecular (INGEMM), IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.ORCID 0009-0007-1931-0390
Natalia GallegoInstituto de Genética Médica y Molecular (INGEMM), IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.ORCID 0000-0002-7523-1474
Felipe Querol-GinerPhysiotherapy in Motion Multispeciality Research Group (PTinMOTION), Department of Physiotherapy, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0002-2590-284X
Jair TenorioInstituto de Genética Médica y Molecular (INGEMM), IdiPaz, Hospital Universitario La Paz, 28046 Madrid, Spain.ORCID 0000-0002-5308-2316
José A López GuerreroDoctoral School, Catholic University of Valencia San Vicente Mártir (UCV), 46002 Valencia, Spain.ORCID 0000-0002-7369-8388
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Hemophilia A is an X-linked disorder characterized by quantitative deficiency of coagulation factor VIII (FVIII) caused by pathogenic variants in the factor 8 (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Comprehensive Screening of Genetic Variants in the Coding Region of · full record | OpenQuestion